When defects occur in the ATM/ATR signaling pathway, both ATM‐mediated HRR and NHEJ repair pathways fail to activate properly, resulting in decreased DSBs repair efficiency, accumulation of intracellular DNA damage, and ultimately increased tumor cell sensitivity to chemotherapeutic agents [43]. This evidence concerns the gene ATM and neoplasm.